Metispharma
1 known investors
Metis Pharma applies AI to design nanomaterials such as lipid nanoparticles (LNPs) for targeted drug delivery, using techniques like molecular dynamics simulation of endosomal escape.
Investors · 1
Frequently asked questions
- What does Metispharma do?
- Metis Pharma applies AI to design nanomaterials such as lipid nanoparticles (LNPs) for targeted drug delivery, using techniques like molecular dynamics simulation of endosomal escape.
- Who are Metispharma's investors?
- Metispharma's investors include Source Code Capital.